← Back
$SAGE All transactions

Sage Therapeutics, Inc.

F

$ Value

$728

Shares

79

Price

$9

Filed

Jun 26

Insider

Name

Shiferman Gregory L.

Title

See Remarks

CIK

0002041689

Roles

Officer

Transaction Details

Transaction Date

2025-06-24

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

30,950

Footnotes

On June 24, 2025, the reporting person vested 234 shares of time-based restricted stock units (RSUs) granted on October 28, 2021 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vested 25% on September 24, 2022, and vests quarterly thereafter in twelve equal installments. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.

Filing Info

Accession No.

0001562180-25-005086

Form Type

4

Issuer CIK

0001597553

Shiferman Gregory L.'s History

Date Ticker Type Value
2026-04-01 VYGR A $0
2026-01-06 VYGR A $0
2025-07-31 SAGE U
2025-07-31 SAGE D
2025-07-31 SAGE D
2025-07-31 SAGE D
2025-06-24 SAGE F $728

Other Insiders at SAGE (90d)

No other insider activity at this issuer in the last 90 days.